CirQuest in NEJM


Our Navigators are pleased to announce the publication of "Antibody-Based Ticagrelor Reversal Agent in Healthy Volunteers" in the latest edition of the New England Journal of Medicine. Our founder and CEO, Dr. Lisa K. Jennings, worked with trailblazing partners from the Brigham and Women’s Hospital Heart and Vascular Center, Harvard Medical School, Thomas Jefferson University, the Thrombosis and Atherosclerosis Research Institute, and PhaseBio Pharmaceuticals to co-author this fascinating study. Visit NEJM to read the publication.


Looking for something in particular? Contact us for our complete list of specialized life science services or more info!

CirQuest Labs
140 Collins Street

Memphis, TN 38112
USA

Phone: 901.866.1700

Fax: 901.866.1702

  • White LinkedIn Icon
  • White Twitter Icon

© 2020 CirQuest Labs All Rights Reserved

Website Built and Designed by Savannah Worcester